Wedbush Starts Aclaris Therapeutis (ACRS) at Outperform

May 28, 2025 6:50 AM EDT Send to a Friend
(Updated - May 28, 2025 7:05 AM EDT)

Wedbush analyst Martin Fan initiates coverage on Aclaris Therapeutis (NASDAQ: ACRS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login